Aptus Pharma Limited Share Price

Aptus Pharma Limited Share Price

BSE: 544529
|
Pharmaceuticals
|
S Cap
₹ 258.20
-₹5.25 (-1.99%)
1D
Last updated 13 Aug, 2026, 15:15 IST

Aptus Pharma Limited Share Price Today

As of 14 Aug 2026, Aptus Pharma Limited share price is ₹258.20. The stock opened at ₹258.20, compared to its previous close of ₹263.45. During today's trading session, Aptus Pharma Limited share price moved in the range of ₹258.20 to ₹258.20, with an average price of ₹258.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹32.32 and a high of ₹310.25.

₹258.20
1.99% down today
₹258.20
1D LOW
1D HIGH

Aptus Pharma Limited Returns Calculator

Circuit
L
H
₹258.20
₹268.70
52-week
L
H
₹32.32
₹310.25

About Aptus Pharma Limited

Aptus Pharma Limited Share Price
ISIN
INE15XJ01010
Sector Market Cap
₹ 451.82 Cr

Aptus Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing a range of medicine solutions which include Anti-Infectives, Antacids and PPI, G.I. Medicines, Anti-Allergic and Respiratory Medicine, Nutritional Supplements, Anti-Inflammatory and Pain Management, Neuro-Psychiatric Medicine, Lipid Lowering Medicine, Anti-Hypertensives and Cardiovascular Medicine, Antidiabetic Medicine, and Consumer Care. Its divisions include Aptus Pharma, Aptus CD Care, Aptus WellCare, and Aptus Global. Its brands include Chilkul, Koltus, Telbira, and Aptirub. Its products include APBILE-150, APBILE-300, APORA 5 CREAM, APTICHYM-FORTE, APTIDA-10, APTIDA-M, APTIDOL-MR, APTIDOX-L, APTIFRESH, APTIFRESH-EC, APTIFRESH-FM, APTIFRESH-LE, APTIFRESH-MD, APTIFRESH-MW, APTIGLIM-M1 FORTE, APTIGLIM-M1 PR, APTIGLIM-M2 FORTE, APTIGLIM-M2 SR, among others.

Aptus Pharma Limited Financial Highlights

  • Revenue: Aptus Pharma Limited reported revenue of ₹46.70 crore in FY26 vs ₹24.64 crore in FY25. It showed an increase of 89.53% on a yearly basis.
  • Operating Profit: Aptus Pharma Limited reported an operating profit of ₹6.37 crore in FY26 vs ₹4.20 crore in FY25. It showed an increase of 51.67% on a year-on-year basis.
  • Net Profit: Aptus Pharma Limited reported a net profit of ₹4.62 crore in FY26 vs ₹2.96 crore in FY25. It showed an increase of 56.08% on a yearly basis.
Know more
Promoters
72.89%
FII
0.00%
Other DII
0.00%
Retail and other
27.11%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
May 20260.00%
Jun 20260.00%
Mkt Cap Cr
451.82
P/E
0.00
P/B
22.16
ROE
19.79%
D/E
0.31
ROCE
23.50%
Div. Yield
0.00%
EPS(TTM)
7.78
Turnover
1.92
EV/EBITDA
0.00
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.00%
Quick Ratio
0.00
Curr. Ratio
2.79
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aptus Pharma outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Aptus Pharma appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.624.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

Aptus Pharma Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹24.56₹17.86₹13.90
Other Income₹0.08₹0.03₹0.00
Total Revenue₹24.64₹17.88₹13.90
Total Expenses₹20.44₹16.76₹13.60
Profit Before Tax₹4.20₹1.12₹0.30
Tax₹1.10₹0.32₹0.10
Profit After Tax₹3.10₹0.80₹0.19
EPS - Basic₹6.37₹5.32₹1.30
EPS - Diluted₹6.37₹5.32₹1.30

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹4.20₹1.12₹0.30
Income before WC changes₹4.85₹1.55₹0.62
Change in Assets-₹7.22-₹3.30-₹1.75
Change in Liabilities₹1.64-₹0.08₹1.07
Change in WC-₹5.57-₹3.38-₹0.68
Cash flow from Operations-₹1.84-₹2.17-₹0.18
Cash flow from Investing-₹0.54-₹0.30-₹0.35
Cash flow from Financing₹6.68₹2.86₹0.81
Total Cash Flow₹4.30₹0.38₹0.28
Cash (Start of the year)₹0.91₹0.54₹0.26
Cash (End of the year)₹5.21₹0.91₹0.54

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹2.18₹1.70₹0.56
Current Assets₹19.74₹8.32₹5.65
Total Assets₹21.92₹10.03₹6.22
Current Liabilities₹12.08₹4.14₹3.13
Net Current Asset₹7.65₹4.19₹2.52
Non-Current Liabilities₹2.87₹4.12₹2.12
Equity Capital₹6.97₹1.77₹0.97
Total Equity & Liabilities₹21.92₹10.03₹6.22
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
258.2
6000
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 6000
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
3
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
48.95
Neutral
ATR (14)
10.54
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
40.51
Bearish
UO(9)
24.17
Bullish
ROC(12)
0.62
Bullish
WillR(14)
-78.57
Neutral
Period
Simple value
Exponential vaue
5D
274.36
272.29
10D
280.74
273.3
20D
266.18
265.88
50D
242.13
240.89
100D
199.2
210.07
Volume trend — traded volume by day
13 Aug0L
12 Aug0L
11 Aug0L
10 Aug0L
7 Aug0L
Average0L
Compare against other stocks
Aptus Pharma Limited Share Price
Aptus Pharma Limited
Pharmaceuticals
Add Stock
Add Another

Aptus Pharma Limited Share Price FAQs